Your browser doesn't support javascript.
loading
Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome.
Anschuetz, Lukas; Hohenberger, Ralph; Kaecker, Christoph; Elicin, Olgun; Giger, Roland; Caversaccio, Marco.
Afiliación
  • Anschuetz L; Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10, 3010, Bern, Switzerland.
  • Hohenberger R; Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10, 3010, Bern, Switzerland. ralph.hohenberger@med.uni-heidelberg.de.
  • Kaecker C; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany. ralph.hohenberger@med.uni-heidelberg.de.
  • Elicin O; Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10, 3010, Bern, Switzerland.
  • Giger R; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Caversaccio M; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
J Otolaryngol Head Neck Surg ; 52(1): 36, 2023 Apr 28.
Article en En | MEDLINE | ID: mdl-37118840
ABSTRACT

BACKGROUND:

To assess a large patient cohort with sinonasal malignancies focusing on regional involvement, recurrence and oncological outcome.

METHODS:

Patients (n = 144) with malignant tumors of the nasal cavity and paranasal sinuses were treated at our tertiary referral center between 2008 and 2019. A chart review on patient and tumor characteristics, treatment and long-term outcome was performed.

RESULTS:

Most frequent histological types were squamous cell carcinoma (SCC) (n = 74), adenocarcinoma (n = 24) and mucosal melanoma (n = 18). Primary therapy was surgery in 66% of patients (n = 95) of which 65.8% (n = 66) received adjuvant radiotherapy. Twenty patients (13.8%) were initially staged as cN + and in seven cases, pN + status was histopathologically confirmed. Fifty-six of 130 patients (43.1%) had a relapse after curative intended therapy, including nine loco-regional (6.9%) and seven isolated regional recurrences (5.4%). Twelve of these 16 patients with (loco-)regional recurrence had SCC. Adenoid cystic carcinoma (87.5%) and SCC (65.3%) showed the best long-term overall survival.

CONCLUSIONS:

Regional involvement and regional recurrence are scarce. Because of rarity and heterogeneity, evidence on therapeutic management is sparse resulting in the lack of clinical guidelines.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de los Senos Paranasales / Carcinoma de Células Escamosas / Adenocarcinoma / Neoplasias Nasales / Carcinoma Adenoide Quístico Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En Revista: J Otolaryngol Head Neck Surg Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de los Senos Paranasales / Carcinoma de Células Escamosas / Adenocarcinoma / Neoplasias Nasales / Carcinoma Adenoide Quístico Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En Revista: J Otolaryngol Head Neck Surg Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza